Cite
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial.
MLA
Witzens, Harig, Mathias, et al. “Rituximab Maintenance Improves Survival in Male Patients with Diffuse Large B-Cell Lymphoma. Results of the HD2002 Prospective Multicentre Randomized Phase III Trial.” British Journal of Haematology, vol. 171, no. 5, Dec. 2015, pp. 710–19. EBSCOhost, https://doi.org/10.1111/bjh.13652.
APA
Witzens, H. M., Benner, A., McClanahan, F., Klemmer, J., Brandt, J., Brants, E., Rieger, M., Meissner, J., Hensel, M., Neben, K., Dreger, P., Lengfelder, E., Schmidt, W. I., Krämer, A., & Ho, A. D. (2015). Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial. British Journal of Haematology, 171(5), 710–719. https://doi.org/10.1111/bjh.13652
Chicago
Witzens, Harig, Mathias, Axel Benner, Fabienne McClanahan, Jennifer Klemmer, Julia Brandt, Elke Brants, Michael Rieger, et al. 2015. “Rituximab Maintenance Improves Survival in Male Patients with Diffuse Large B-Cell Lymphoma. Results of the HD2002 Prospective Multicentre Randomized Phase III Trial.” British Journal of Haematology 171 (5): 710–19. doi:10.1111/bjh.13652.